GeneGene: ATR
ATR kinase
ATR is a master kinase of the DNA-damage response that lets tumor cells survive replication stress. ATR inhibitors aim to overwhelm cancer cells with unrepaired damage and, in combination with immunotherapy, to make tumors more visible to the immune system.
1
Drugs
1
Trials tracked
0
Resolved
1
Indications
Drugs hitting this target
Trials targeting ATR
1 benchmarkIndications
About ATR
What is ATR?
ATR is a master kinase of the DNA-damage response that lets tumor cells survive replication stress. ATR inhibitors aim to overwhelm cancer cells with unrepaired damage and, in combination with immunotherapy, to make tumors more visible to the immune system.
Which drugs target ATR?
Therapies acting on ATR tracked here include Ceralasertib.